Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03006848
Title A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications
Therapies
Age Groups: adult | child
Covered Countries USA


No variant requirements are available.